Phase I Study of Hemay102 in Patients With Advanced Solid Tumors
Clinical trial NCT03982303 · UNKNOWN
Trial details
- NCT number
- NCT03982303
- Sponsor
- Tianjin Hemay Oncology Pharmaceutical Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-03
- Primary completion
- 2021-12-31
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.